Table 2.
Disease models used in simulation study
| Risk | A/A | A/a | a/a |
|---|---|---|---|
| Model 1 | |||
| B/B | 1 | 1 + θ | (1 + θ)2 |
| B/b | 1 + θ | (1 + θ)2 | (1 + θ)3 |
| b/b | (1 + θ)2 | (1 + θ)3 | (1 + θ)4 |
| Model 2 | |||
| B/B | 1 | 1 | 1 |
| B/b | 1 | (1 + θ)2 | (1 + θ)3 |
| b/b | 1 | (1 + θ)3 | (1 + θ)4 |
| Model 3 | |||
| B/B | 1 | 1 | 1 |
| B/b | 1 | 1 + θ | 1 + θ |
| b/b | 1 | 1 + θ | 1 + θ |
Each table cell lists the relative risk of the corresponding genotype combination. Genotypes with risks equal to 1 have no effects to the disease. The parameter θ is computed according to the specified marginal effects (0.5 in our simulation) and disease MAFs (0.05, 0.1, 0.2, 0.5).